BioMedNewsBreaks – Brain Scientific Inc. (BRSF) Appoints Experienced Innovator as VP of Strategy

November 3, 2020 12:03:22

Brain Scientific (OTCQB: BRSF), a neurology-focused medical device and software company, has announced the appointment of a new vice president of strategy and business development. In her new role, Amy Griffith will be responsible for the company’s development of strategic and tactical initiatives, as well as new sales strategies. A veteran sales and innovation expert, Griffith has held executive management positions at leading technology companies and has also worked with start-ups, focusing on identifying and implementing strategic sales programs. With an expertise in the medical and health-care industry, Griffith has been deeply involved and brings impressive experience in strategic planning and relationship building, market expansion, contract negotiation, and competitive intelligence. Her work at GlaxoSmithKline involved promoting a product portfolio to several hundred psychiatrists, neurologists, internists, OB/GYN and family practice physicians. “We are excited to have Amy on our team,” said Brain Scientific chairman Boris Goldstein in the press release. “She has been consistently awarded for goal-exceeding performance throughout her extensive career. Ms. Griffith has an exceptional knowledge of the neurology market and has the expertise to implement sales processes that drive revenue and enhance market share,”

To view the full press release, visit

About Brain Scientific

Brain Scientific is a commercial-stage, health-care company with two FDA-cleared products, providing next-gen solutions to the neurology market. The company’s smart diagnostic devices and sensors simplify administration, shorten scan time and cut costs, allowing clinicians to make rapid decisions remotely and bridge the widening gap in access to neurological care. For more information about this company, please visit

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published:

BioMedWire (BMW)
San Francisco, California
415.949.5050 Office

BioMedWire is part of the InvestorBrandNetwork